<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/54F9413B-19F2-46DE-AFD4-245E4FB19B79"><gtr:id>54F9413B-19F2-46DE-AFD4-245E4FB19B79</gtr:id><gtr:name>Stellenbosch University</gtr:name><gtr:address><gtr:line1>Private Bag X1</gtr:line1><gtr:line2>19 Jonkershoek Road</gtr:line2><gtr:line3>Matieland</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/92F81743-12CA-4C06-9CDF-5AB4B09B6F38"><gtr:id>92F81743-12CA-4C06-9CDF-5AB4B09B6F38</gtr:id><gtr:name>Sir Charles Gairdner Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D5FA451D-4FA7-423E-93F8-046141371F35"><gtr:id>D5FA451D-4FA7-423E-93F8-046141371F35</gtr:id><gtr:name>University of Western Australia</gtr:name><gtr:address><gtr:line1>35 Stirling Highway</gtr:line1><gtr:line4>Crawley</gtr:line4><gtr:line5>WA 6009</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F20FFE5B-3DA6-4629-894F-4CE13B49B4E4"><gtr:id>F20FFE5B-3DA6-4629-894F-4CE13B49B4E4</gtr:id><gtr:name>Vanderbilt University</gtr:name><gtr:address><gtr:line1>Vanderbilt University</gtr:line1><gtr:line2>2201 West End Avenue</gtr:line2><gtr:line4>Nashville</gtr:line4><gtr:line5>Tennessee</gtr:line5><gtr:postCode>TN 37235</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Clinical Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/54F9413B-19F2-46DE-AFD4-245E4FB19B79"><gtr:id>54F9413B-19F2-46DE-AFD4-245E4FB19B79</gtr:id><gtr:name>Stellenbosch University</gtr:name><gtr:address><gtr:line1>Private Bag X1</gtr:line1><gtr:line2>19 Jonkershoek Road</gtr:line2><gtr:line3>Matieland</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/92F81743-12CA-4C06-9CDF-5AB4B09B6F38"><gtr:id>92F81743-12CA-4C06-9CDF-5AB4B09B6F38</gtr:id><gtr:name>Sir Charles Gairdner Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5FA451D-4FA7-423E-93F8-046141371F35"><gtr:id>D5FA451D-4FA7-423E-93F8-046141371F35</gtr:id><gtr:name>University of Western Australia</gtr:name><gtr:address><gtr:line1>35 Stirling Highway</gtr:line1><gtr:line4>Crawley</gtr:line4><gtr:line5>WA 6009</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F20FFE5B-3DA6-4629-894F-4CE13B49B4E4"><gtr:id>F20FFE5B-3DA6-4629-894F-4CE13B49B4E4</gtr:id><gtr:name>Vanderbilt University</gtr:name><gtr:address><gtr:line1>Vanderbilt University</gtr:line1><gtr:line2>2201 West End Avenue</gtr:line2><gtr:line4>Nashville</gtr:line4><gtr:line5>Tennessee</gtr:line5><gtr:postCode>TN 37235</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B04AE213-F76F-4162-B08C-F97885212230"><gtr:id>B04AE213-F76F-4162-B08C-F97885212230</gtr:id><gtr:firstName>Najib</gtr:firstName><gtr:surname>Rahman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1001128"><gtr:id>C4C8C298-ADAC-46DE-9A0A-A413F3230136</gtr:id><gtr:title>The prospective testing of the accuracy of a prognosis prediction score in pleural infection</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1001128</gtr:grantReference><gtr:abstractText>Pleural infection describes infected fluid collecting between the lung and chest wall. There are around 80,000 new cases each year (US+UK), of which 35% are either fatal or require chest surgery. Standard treatment involves antibiotics and drainage of infected fluid, achieved through a tube placed in the chest. If this fails, surgical drainage is required, but we currently do not have a reliable way of identifying which patients will need surgery. Prompt surgery may be life saving in needy cases, but it is also associated with major complications and results in a substantial amount of pain. Thus, targeting surgery to those who need it most is important. This study will test a prediction tool which may allow us to identify ?high risk? who may benefit most from surgery. 
The proposed test is a risk prediction score calculated on admission to hospital. Previous data suggests it may be possible to predict patients who would die from their pleural infection from five test results which are routinely collected in clinical practice. While these predictors seem very powerful, they need to be tested in ?real world? use. In addition, other work suggests that the type of bacteria responsible for the infection may predict death, and these factors will also be explored as possible ?predictors?. 
This study will collect information about 550 pleural infection patients, recruited from UK, Europe, USA and the Far East. All patients will receive the best available treatment, including antibiotics, chest drainage and surgery if needed. We will record which patients die or need surgery. At the end of the study, we will calculate whether the ?predictors? identify patients at high risk of death.
The team conducting this research have previously successfully completed many studies in this area. Together the research team holds #45m of clinical research funding. If the score tested here turns out to be a good way predict which patients will do badly, this can be immediately used to change how we treat patients with this disease.</gtr:abstractText><gtr:technicalSummary>This proposal is to test a potentially powerful, novel, low-cost, and readily translatable prediction model that could be applied at presentation to all patients with pleural infection. If it is successful in prospective clinical testing, this model would allow clinicians to reliably identify subjects with pleural infection at high risk of death and poor outcome to receive targeted extra supportive care, surgery, and newer complex and expensive intrapleural interventions. Successful completion of this study would result in an immediately applicable score, which could be rapidly disseminated into care through specialist care guidelines. 
 The core of the prediction model is a combination score based on the blood urea, albumin, blood pressure, age, and the source of the infection. These factors have been identified using regression analysis from a previous large cohort of patients with pleural infection, and now require prospective testing. This clinical model will be combined with bacterial markers of prognosis recordable at baseline to create a novel multimodality score.
 If it is successful in prospective clinical testing, it would allow clinicians to reliably identify subjects at high risk of death and poor outcome to receive targeted extra supportive care, surgery, and potentially the complex and expensive intrapleural interventions that have recently shown efficacy in clinical trials conducted by our unit.</gtr:technicalSummary><gtr:fund><gtr:end>2018-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>483803</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Medical Sciences Division</gtr:department><gtr:description>Microbiology collaboration</gtr:description><gtr:id>84367B9B-158F-4A5B-90E7-17C443C5E1E3</gtr:id><gtr:impact>Nil thus far</gtr:impact><gtr:outcomeId>orKaTdjUXQW-1</gtr:outcomeId><gtr:partnerContribution>Advice has been received from collaborators in microbiology on optimal sample collection and storage for this future collaboration</gtr:partnerContribution><gtr:piContribution>Prospectively collected samples will be used to assess the microbiological profile of pleural infection, and tested using novel DNA based techniques.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sir Charles Gairdner Hospital</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Lung Institute of Western Australia (LIWA)</gtr:department><gtr:description>Western Australia</gtr:description><gtr:id>46907561-35EA-4914-B70B-0916DABD7530</gtr:id><gtr:impact>The genetic profiling of malignant pleural disease, and specifically malignant mesothelioma, is a collaborative project formed between our unit and our collaborators. Our collaborators have an interest in the biology and physiological mechanisms behind malignant pleural disease and pleurodesis. The TIME1 trial has permitted the set up of a biobank of pleural fluid samples with associated clinical information, allowing meaningful translational work to be conducted.</gtr:impact><gtr:outcomeId>AD2A595DA36-1</gtr:outcomeId><gtr:partnerContribution>Analysis of genetic markers of mesothelioma; investigation of the biology of pleurodesis permitting translation of novel molecules to the clinical setting</gtr:partnerContribution><gtr:piContribution>Contribution of clinical samples and clinical data</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Stellenbosch</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>INTERNATIONAL RESEARCH PARTNERSHIP</gtr:description><gtr:id>2EC256CD-5863-45C2-932E-89702D8C40A2</gtr:id><gtr:impact>Recruitment to current study, discussion around potential recruitment to future studies</gtr:impact><gtr:outcomeId>56e07ad9a514d5.34869596-2</gtr:outcomeId><gtr:partnerContribution>Recruitment to trials, input on to trial committees</gtr:partnerContribution><gtr:piContribution>Through the MRC grant to conduct the PILOT study, we have established an international recruitment base for pleural trials which includes centres in Australia, the USA and South Africa. These are now actively recruiting patients to the trial and will be used in future for large scale pleural trials.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Vanderbilt University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Vanderbilt Medical Center</gtr:department><gtr:description>INTERNATIONAL RESEARCH PARTNERSHIP</gtr:description><gtr:id>A87563BB-51DB-4223-BDBE-19B368B2C1A4</gtr:id><gtr:impact>Recruitment to current study, discussion around potential recruitment to future studies</gtr:impact><gtr:outcomeId>56e07ad9a514d5.34869596-1</gtr:outcomeId><gtr:partnerContribution>Recruitment to trials, input on to trial committees</gtr:partnerContribution><gtr:piContribution>Through the MRC grant to conduct the PILOT study, we have established an international recruitment base for pleural trials which includes centres in Australia, the USA and South Africa. These are now actively recruiting patients to the trial and will be used in future for large scale pleural trials.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Western Australia</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>INTERNATIONAL RESEARCH PARTNERSHIP</gtr:description><gtr:id>FD298272-FAD7-4D4B-AD93-CA94A534B161</gtr:id><gtr:impact>Recruitment to current study, discussion around potential recruitment to future studies</gtr:impact><gtr:outcomeId>56e07ad9a514d5.34869596-3</gtr:outcomeId><gtr:partnerContribution>Recruitment to trials, input on to trial committees</gtr:partnerContribution><gtr:piContribution>Through the MRC grant to conduct the PILOT study, we have established an international recruitment base for pleural trials which includes centres in Australia, the USA and South Africa. These are now actively recruiting patients to the trial and will be used in future for large scale pleural trials.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>ERS</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>86F9FF27-B25F-4552-BE7E-7097B72E8E96</gtr:id><gtr:impact>Asked to present data from malignant and infective pleural trials conducted by my group at the European Respiratory Society Conference, Vienna 2012

Several requests to host fellows in my research department, increased potential european collaborators</gtr:impact><gtr:outcomeId>pAgBxZWLTx8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK Pleural Research Day 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FE2F1196-84A9-47D6-9F2B-10170D111A02</gtr:id><gtr:impact>We hosted a national pleural research day attended by 100 delegates who were respiratory research teams from around the UK and with international speakers. This discussed a number of pleural trials including PILOT and RAMMP, generating significant interest.</gtr:impact><gtr:outcomeId>56e07d6ac25750.41463246</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Study participants or study members</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>USA (ATS and ACCP)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>017E8B5F-2233-4EDD-BD04-50552BC222CE</gtr:id><gtr:impact>Requested to give keynote talks on pleural malignancy and infection at the American College of Chest Physicians (Atlanta, 2012), the American Thoracic Society (San Francisco, 2012)

Several requests to host international fellows in my research group, increased potential international collaborators for future projects</gtr:impact><gtr:outcomeId>DVqDHCTHeto</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>3000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Oxford Health Sciences Research Committee</gtr:description><gtr:end>2014-01-02</gtr:end><gtr:fundingOrg>Oxford University Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>8D3F568D-72CE-4FE6-A451-71525B2372D4</gtr:id><gtr:outcomeId>BbYwzDj4N85</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ERS RESPIRE2 fellowship scheme</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>European Respiratory Society (ERS)</gtr:fundingOrg><gtr:id>A4339AB0-940E-464B-855B-8C295C598435</gtr:id><gtr:outcomeId>56e0b13a506199.89651847</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Through these two studies (PILOT and RAMMP), we have gained experience and are using the OpenClinica research tool to gather data. This is now occurring highly successfully, and will be used for future funded studies.</gtr:description><gtr:id>6EAFFE10-9EAF-438D-84A2-BF6E30943DAD</gtr:id><gtr:impact>We will use electronic data capture and design for our future studies.</gtr:impact><gtr:outcomeId>56e07ddb1ac786.46030794</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>OpenClinica experience</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C684EC0B-F5A0-4308-8E04-F44DED5ACE6F</gtr:id><gtr:title>Precision-guided, Personalized Intrapleural Fibrinolytic Therapy for Empyema and Complicated Parapneumonic Pleural Effusions: The Case for the Fibrinolytic Potential.</gtr:title><gtr:parentPublicationTitle>Clinical pulmonary medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bc72b072fe77f1af99613e743cf664f"><gtr:id>0bc72b072fe77f1af99613e743cf664f</gtr:id><gtr:otherNames>Idell S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1068-0640</gtr:issn><gtr:outcomeId>5aa6f746e3a7a9.25628276</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A93048DF-ECA9-42A1-948B-6B4E5BF60095</gtr:id><gtr:title>Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2cc97743e003c4129153149838cf513"><gtr:id>d2cc97743e003c4129153149838cf513</gtr:id><gtr:otherNames>Clive AO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1470-2045</gtr:issn><gtr:outcomeId>58c3e6a401adf6.50640734</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A46003A-F38E-47A4-817F-DE117954CC1F</gtr:id><gtr:title>Chest Drain Size: the Debate Continues.</gtr:title><gtr:parentPublicationTitle>Current pulmonology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b5beac8622dd9071ba5403c8696b4b5"><gtr:id>6b5beac8622dd9071ba5403c8696b4b5</gtr:id><gtr:otherNames>Hallifax RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aa6f747a968d1.31317369</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E012B268-968E-4EEA-9D15-DDC91D6E22AD</gtr:id><gtr:title>Advanced medical interventions in pleural disease.</gtr:title><gtr:parentPublicationTitle>European respiratory review : an official journal of the European Respiratory Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75087956bb3e646d0f56394959637f4b"><gtr:id>75087956bb3e646d0f56394959637f4b</gtr:id><gtr:otherNames>Bhatnagar R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0905-9180</gtr:issn><gtr:outcomeId>58c3e6a459aec0.02010619</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A11AFB8E-6C1D-4E54-BC51-A48CEB26D152</gtr:id><gtr:title>Provision of Day-Case Local Anesthetic Thoracoscopy: A Multicenter Review of Practice.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/050f4db41545986e092b4297af4f763d"><gtr:id>050f4db41545986e092b4297af4f763d</gtr:id><gtr:otherNames>Psallidas I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>58c3e6a36dbcc3.28645629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DA4F3EE-8FA3-43C7-95E4-7A2FF1C73CF5</gtr:id><gtr:title>CT sensitivity in pleural malignancy versus thoracoscopy</gtr:title><gtr:parentPublicationTitle>British Thoracic Society Conference 2012</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/892883354663fe1eb9a0d9b03170fb48"><gtr:id>892883354663fe1eb9a0d9b03170fb48</gtr:id><gtr:otherNames>Hallifax</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>RPjU8tsTPzx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43B255DA-CF8B-4178-B1EF-18C229BCE751</gtr:id><gtr:title>Absence of Atypical Pathogens in Pleural Infection.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ddb8d1479f6e741b415fc45aeff3548"><gtr:id>8ddb8d1479f6e741b415fc45aeff3548</gtr:id><gtr:otherNames>Wrightson JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>56e0798cbdca94.64874326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8335DCE8-59F0-4541-B0C0-FD658EE29ACC</gtr:id><gtr:title>Sensitivity of cutting needle biopsies in malignant pleural effusion</gtr:title><gtr:parentPublicationTitle>British Thoracic Society Conference 2012</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58a09b98edd7a41ef4d74761af085834"><gtr:id>58a09b98edd7a41ef4d74761af085834</gtr:id><gtr:otherNames>Hallifax, Robert</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>BrQbkovcgrc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54C9AD75-BBDF-4FEE-B2D8-389451586608</gtr:id><gtr:title>Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8a854b15d222632f64221d2afe25460"><gtr:id>e8a854b15d222632f64221d2afe25460</gtr:id><gtr:otherNames>Mishra EK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>5aa6f7472c1bf9.87555260</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40AC88F7-A46A-46F8-B28E-48DA2D80FC08</gtr:id><gtr:title>A pilot feasibility study in establishing the role of ultrasound-guided pleural biopsies in pleural infection (The AUDIO study).</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/050f4db41545986e092b4297af4f763d"><gtr:id>050f4db41545986e092b4297af4f763d</gtr:id><gtr:otherNames>Psallidas I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>5aa6f744cfdfa3.61014684</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B6F74AB-CCB9-4807-8CCF-7102A0E80318</gtr:id><gtr:title>Picking the winners: Outcome prediction in pleural disease.</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddf599c71320cbc39660b2c1596405e6"><gtr:id>ddf599c71320cbc39660b2c1596405e6</gtr:id><gtr:otherNames>Corcoran JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>5aa6f746302483.30269477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3B82A11-602A-4414-9CF0-1C85DDA9C837</gtr:id><gtr:title>The inspired sinewave technique: A novel method to measure lung volume and ventilatory heterogeneity.</gtr:title><gtr:parentPublicationTitle>Experimental physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de00d4e4a4421b2164965225fcb0a925"><gtr:id>de00d4e4a4421b2164965225fcb0a925</gtr:id><gtr:otherNames>Bruce RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0958-0670</gtr:issn><gtr:outcomeId>5aa6f745eb3f64.83143273</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE7A382F-122F-4AA8-85C1-1E6B08B6DA81</gtr:id><gtr:title>The role of pleurodesis in respiratory diseases.</gtr:title><gtr:parentPublicationTitle>Expert review of respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe0c38df0c0ce69380b0103c7bcd0d0"><gtr:id>0fe0c38df0c0ce69380b0103c7bcd0d0</gtr:id><gtr:otherNames>Mercer RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1747-6348</gtr:issn><gtr:outcomeId>5aa6f7453a46f2.98294455</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B73693F-474B-4334-A055-FF3C3B94534C</gtr:id><gtr:title>Anatomy and physiology of the pleural space</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59eedb0369bde0ade72bf21c72414357"><gtr:id>59eedb0369bde0ade72bf21c72414357</gtr:id><gtr:otherNames>Corcoran J and Rahman NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:isbn>978-0470654743</gtr:isbn><gtr:outcomeId>QS6no3Jjiei</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02C54D3B-7656-4118-BD69-934601EF81DB</gtr:id><gtr:title>Pneumocystis jirovecii in pleural infection: a nucleic acid amplification study.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ddb8d1479f6e741b415fc45aeff3548"><gtr:id>8ddb8d1479f6e741b415fc45aeff3548</gtr:id><gtr:otherNames>Wrightson JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5463f147a76f80.16511538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E4F0EC4-5D5A-4D04-9FCA-22B33A0DE410</gtr:id><gtr:title>Systematic Review of Microbiology in Pleural Infection</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82e35f00dcc09568994b022170aa4a1c"><gtr:id>82e35f00dcc09568994b022170aa4a1c</gtr:id><gtr:otherNames>Corcoran, John</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>qiMPdZMw89C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A4C79C9-8F20-4782-ABA1-DB64FCBF337A</gtr:id><gtr:title>Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns.</gtr:title><gtr:parentPublicationTitle>Annals of the American Thoracic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bc72b072fe77f1af99613e743cf664f"><gtr:id>0bc72b072fe77f1af99613e743cf664f</gtr:id><gtr:otherNames>Idell S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2325-6621</gtr:issn><gtr:outcomeId>5aa6f7466f94c5.64324770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C0D2CBC-84E2-4E62-9645-544FB779231C</gtr:id><gtr:title>British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd726c06396d645831f2964753a82c6f"><gtr:id>bd726c06396d645831f2964753a82c6f</gtr:id><gtr:otherNames>Woolhouse I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5aa6f74571df71.81081922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18995757-7E87-4A0A-8DC9-F40971749BCC</gtr:id><gtr:title>State of the art thoracic ultrasound: intervention and therapeutics.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddf599c71320cbc39660b2c1596405e6"><gtr:id>ddf599c71320cbc39660b2c1596405e6</gtr:id><gtr:otherNames>Corcoran JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5aa6f74773a298.91874799</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E7A76D1-CCCD-4E32-86A1-4C89EABC6F7F</gtr:id><gtr:title>Management of parapneumonic effusions and empyema.</gtr:title><gtr:parentPublicationTitle>Seminars in respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/050f4db41545986e092b4297af4f763d"><gtr:id>050f4db41545986e092b4297af4f763d</gtr:id><gtr:otherNames>Psallidas I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1069-3424</gtr:issn><gtr:outcomeId>56e0798fb5ea96.75151045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24A07C40-94A9-4F12-BF69-9C290F6CBFFC</gtr:id><gtr:title>Pleural infection: past, present, and future directions.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddf599c71320cbc39660b2c1596405e6"><gtr:id>ddf599c71320cbc39660b2c1596405e6</gtr:id><gtr:otherNames>Corcoran JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>56e0798ce41ce4.06710100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A74314F0-2772-493C-B8EB-363AC761C9C1</gtr:id><gtr:title>Blood culture bottle culture of pleural fluid in pleural infection.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/487cf2b78de92bc1475341b29ea2797a"><gtr:id>487cf2b78de92bc1475341b29ea2797a</gtr:id><gtr:otherNames>Menzies SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>5463f148582a59.85289541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF1E69CE-91F0-446B-936B-30A08A286A22</gtr:id><gtr:title>Novice versus experts in digital assessment of pleural shadowing in pleural infection</gtr:title><gtr:parentPublicationTitle>British Thoracic Society Conference 2012</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58a09b98edd7a41ef4d74761af085834"><gtr:id>58a09b98edd7a41ef4d74761af085834</gtr:id><gtr:otherNames>Hallifax, Robert</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>C5stNSpyYhx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9CF7DB8-7B4E-42D1-998E-AF73D24F4CD2</gtr:id><gtr:title>New therapeutic approaches to pleural infection.</gtr:title><gtr:parentPublicationTitle>Current opinion in infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddf599c71320cbc39660b2c1596405e6"><gtr:id>ddf599c71320cbc39660b2c1596405e6</gtr:id><gtr:otherNames>Corcoran JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0951-7375</gtr:issn><gtr:outcomeId>oeufSY6joAk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50C47408-4D6E-423E-B481-C9BA425F4BC6</gtr:id><gtr:title>Advances in pleural disease.</gtr:title><gtr:parentPublicationTitle>European respiratory review : an official journal of the European Respiratory Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/050f4db41545986e092b4297af4f763d"><gtr:id>050f4db41545986e092b4297af4f763d</gtr:id><gtr:otherNames>Psallidas I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0905-9180</gtr:issn><gtr:outcomeId>58c3e6a48dd4d3.27246417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3B91F71-B563-4629-AD95-2F78EA685C1E</gtr:id><gtr:title>Fibrin Turnover and Organization of Pleural Injury: Bench to Bedside.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Lung cellular and molecular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d1d928c531ab6fa1201b1638448c3c9"><gtr:id>4d1d928c531ab6fa1201b1638448c3c9</gtr:id><gtr:otherNames>Komissarov AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1040-0605</gtr:issn><gtr:outcomeId>5aa6f746a87c19.36544182</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C42E3295-9B80-46FA-BCD3-5C8432903029</gtr:id><gtr:title>Malignant Pleural Effusion: From Diagnostics to Therapeutics.</gtr:title><gtr:parentPublicationTitle>Clinics in chest medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f75d0b5652c04736625ee9aaf224dc4"><gtr:id>9f75d0b5652c04736625ee9aaf224dc4</gtr:id><gtr:otherNames>Asciak R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0272-5231</gtr:issn><gtr:outcomeId>5aa6f745b3b0c6.62038814</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>244B00AF-86D6-4F07-AC67-5AB3ACD3DCDB</gtr:id><gtr:title>Prognostication and monitoring of mesothelioma using biomarkers: a systematic review.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/717fb6acab2e2d5beb5c1a5b65903b70"><gtr:id>717fb6acab2e2d5beb5c1a5b65903b70</gtr:id><gtr:otherNames>Arnold DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>58c3e6a39b43d8.31667331</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>851587F3-5900-4ED6-B5E6-3995E50E4479</gtr:id><gtr:title>A retrospective validation study of three models to estimate the probability of malignancy in patients with small pulmonary nodules from a tertiary oncology follow-up centre.</gtr:title><gtr:parentPublicationTitle>Clinical radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fad83689a9dab92dba51d7803d334bb9"><gtr:id>fad83689a9dab92dba51d7803d334bb9</gtr:id><gtr:otherNames>Talwar A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0009-9260</gtr:issn><gtr:outcomeId>5aa6f747e58175.24926018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C3FA349-D991-4D86-B36E-59341B4125B9</gtr:id><gtr:title>Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d003cc52d23b4ffd96cbb1cfbe75073"><gtr:id>6d003cc52d23b4ffd96cbb1cfbe75073</gtr:id><gtr:otherNames>Olfert JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>58c3e6a3c58bd2.88294349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88360100-EC5C-436B-B4F1-CB4D3C2620C0</gtr:id><gtr:title>3 month outcomes in radiology from the MIST2 study</gtr:title><gtr:parentPublicationTitle>British Thoracic Society Conference 2012</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58a09b98edd7a41ef4d74761af085834"><gtr:id>58a09b98edd7a41ef4d74761af085834</gtr:id><gtr:otherNames>Hallifax, Robert</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>QJjSR7N6DS2</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1001128</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>